Purpose: To compare the effect of phacoemulsification (Phaco) versus combined phacoemulsification and viscogonioplasty (Phaco-VGP) on long-term intraocular pressure (IOP) in primary angleclosure glaucoma (PACG).
P rimary angle-closure glaucoma (PACG) occurs when the anterior chamber (AC) drainage angle progressively narrows with a subsequent rise in intraocular pressure (IOP) leading to glaucomatous optic neuropathy. 1 Recent evidence indicates that a thickened and anterior-positioned lens plays a crucial role in the pathogenesis of PACG, especially in elderly individuals, and that lens extraction is effective in deepening the AC, opening the iridocorneal angle, and lowering the IOP. [2] [3] [4] [5] [6] [7] However, in chronic cases the trabecular meshwork may remain occluded by peripheral anterior synechiae (PAS) despite AC deepening. In these eyes the trabecular meshwork can be exposed again if PAS are broken by separating the adherent iris from the meshwork. Theoretically, goniosynechialysis can restore trabecular function in eyes with PACG by stripping PAS from the angle and exposing the underlying trabecular meshwork. [8] [9] [10] Although viscogonioplasty (VGP) has been introduced for breaking PAS in PACG by using heavy viscoelastics like Healon [Abbott Medical Optics (AMO), Abbott Park, IL], 9-13 recurrence of PAS or permanent damage to the trabecular meshwork might cause the goniosynechialysis to fail to regain aqueous outflow in the long term. 14, 15 In the literature combined phacoemulsification (Phaco) and viscogoniosynechialysis was an effective and safe treatment for management of angle-closure glaucoma. [9] [10] [11] [12] [13] 16 Our previous publication revealed that goniosynechialysis may have some additional effect on drainage angle anatomy. 17 However, few studies have assessed the effect of additional goniosynechialysis to Phaco on long-term IOP in PACG patients.
The objective of this randomized clinical trial is to compare the effects of Phaco alone versus combined phacoemulsification and viscogonioplasty (Phaco-VGP) on long-term IOP and anterior segment parameters in PACG eyes. We used anterior segment optical coherence tomography (AS-OCT) to assess the AC and angle parameters, and evaluated the variables that affect IOP control in PACG eyes after Phaco. This device provides a noncontact assessment of the AC and angle parameters, and allows users to quantify angle width and measure AC dimensions and parameters including novel factors such as lens vault (LV), thus helping researchers in further understanding the pathogenesis of anterior segment disease. [18] [19] [20] 
PATIENTS AND METHODS
This was a prospective randomized clinical trial conducted in Farabi Eye Hospital, Tehran, Iran. The Farabi Angle Closure Study (FACS) protocol followed the tenets of the Declaration of Helsinki and was approved by the Farabi Hospital Research Ethics Committee and registered with Iranian Registry of Clinical Trial (IRCT). Patients visiting the glaucoma clinic, from October 2009 to February 2012 were prospectively enrolled in the study if they met the inclusion and exclusion criteria. Written informed consent was obtained from all patients before enrollment.
Inclusion criteria included: (1) PACG defined by at least 270 degrees of iridotrabecular contact (appositional or synechial on gonioscopy) and glaucomatous optic neuropathy determined by optic disc cupping and glaucomatous visual field loss; (2) synechial closure of at least 90 degrees; (3) visually significant cataract with best-corrected visual acuity (VA) of worse than 20/30; (4) IOP < 35 mm Hg; and (5) patent peripheral iridotomy. Exclusion criteria were: (1) eyes with a history of an acute or subacute attack of angleclosure glaucoma; (2) presence of any cause of secondary glaucoma including uveitic glaucoma, neovascular glaucoma, exfoliative glaucoma, and phacomorphic glaucoma; and (3) history of any previous incisional eye surgery.
Examinations included VA testing with manifest refraction, IOP measurement by Goldmann applanation tonometry, complete slit-lamp and fundus examination, and gonioscopy (described in detail below). IOP measurement, optic disc evaluation, and gonioscopy were performed by a single glaucoma specialist (G.L.). Additional preoperative data gathered included demographic information and antiglaucoma medications. For all patients, axial length and lens thickness were measured using A scan ultrasound (Echoscan, model U3300; Nidek Inc., Tokyo, Japan).
Gonioscopy
Subjects underwent gonioscopy preoperatively and during follow-up visit, by a single glaucoma specialist who was masked to the AS-OCT images and findings. Patients were examined in low light conditions with a Zeiss-style 4-mirror goniolens (Model G-4; Volk Optical, Mentor, OH). A narrow 1-mm beam of light was USED; a vertical beam was used to evaluate the superior and inferior angles, whereas a horizontal beam was used for the nasal and temporal angles. All 4 quadrants were assessed with the eye in the primary position of gaze; slight tilting of the lens was allowed if there was significant LV. The angle was graded using the Spaeth grading system. Average of the gonioscopic grading in the 4 quadrants was defined as the gonioscopic grade for each eye. 19 Indentation gonioscopy was used to establish the presence and extent of PAS. PAS were defined as abnormal adhesions of the iris to the angle to the level of the trabecular meshwork, which are at least 15 degrees in width and could not be broken with indentation gonioscopy. The extent of PAS was noted in degrees. The data from last visit was used for statistical analysis. 21 
AS-OCT
AS-OCT (Visante OCT; Carl Zeiss Meditec, Dublin, CA) was performed for all the patients preoperatively and 1 year after surgery, under dark conditions. Scans were centered on the undilated pupil, and were obtained along horizontal and vertical axes using the enhanced anterior segment single protocol. The same examiner, who was masked to clinical findings, obtained all images. Three consecutive images were captured, and the image with the best quality regarding centration and visibility of the scleral spurs was chosen for analysis. Measurements were conducted by 2 observers who were masked to the patients' gonioscopy findings and type of intervention. Although images of all 4 angle quadrants were captured, images of the inferior and superior quadrants were not included in the analysis because of suboptimal image quality and previously reported poor reproducibility of the measurements.
Angle parameters measured were trabecular-iris space area (TISA) at 500 and 750 mm from the scleral spur, in the temporal and nasal quadrants. The mean of the nasal and temporal TISA500 and TISA750 were labeled as TISA500 and TISA750, respectively. AC depth was defined as the distance from the endothelium at the center of the cornea to the anterior pole of the cataractous lens or intraocular lens (IOL). LV was defined as the perpendicular distance between the anterior lens surface to the horizontal line connecting the 2 scleral spurs, 20 and was measured by the chamber tool of the machine.
Randomization of Subjects and Sample Size
Patients were randomized into 2 groups using computer-generated random blocks to receive either cataract extraction alone (Phaco alone group) or cataract extraction with VGP (Phaco-VGP group). An investigator with no clinical involvement in the trial consecutively assigned each patient enrolled by the clinical investigators to one of the 2 groups according to the random blocks. Patients and clinical investigators who performed gonioscopy, AS-OCT, and IOP measurement were masked to the treatment arm.
Cataract Surgical Technique
Surgery was performed by a single surgeon (S.M.) in all subjects under topical anesthesia. Surgery consisted of routine Phaco (phaco chop technique) through a 3.2-mm temporal clear corneal incision, with an in-the-bag onepiece acrylic IOL (AcrySof SA60AT; Alcon Laboratories Inc., Fort Worth, TX) implantation. Cohesive viscoelastic (Amvisc; Bausch & Lomb Inc., Rochester, NY) was used before capsulorhexis to deepen but not "overfill" the AC. Fritz Ruck Pentasys 2 (Ophthalmologische Systeme GmbH, Eschweiler, Germany) was used in all cases, with a vacuum of 350 mm Hg, maximum ultrasound power of 30%, and an IOP-set of 70 mm Hg.
VGP Technique
Following IOL implantation a cohesive viscoelastic (Amvisc; Bausch & Lomb Inc.) was used to deepen the AC and was then injected near the angle for 360 degrees twice without touching the angle with the cannula. Synechalysis in the inferior, nasal, and superior angles was performed through the temporal corneal incision. Synechalysis in the temporal quadrant was performed through the side port. No surgical instruments were used to physically break the PAS. After completion of VGP, the viscoelastic was meticulously removed.
All patients received oral acetazolamide 250 mg 3 times a day for 24 hours, topical antibiotics 4 times a day for 1 week, as well as topical 1% prednisolone acetate every 2 hours which was tapered gradually over 1 month. Antiglaucoma medications were discontinued postoperatively and restarted if needed.
Randomization of Subjects and Sample Size
The primary outcome measures were IOP and the number of IOP-lowering medications after 1 year. For an SD of 3 mm Hg, we needed 37 patients in each group to achieve an 80% power to detect a difference of 2 mm Hg in final IOP between the 2 groups with a P-value of 0.05. Secondary outcome measures included angle and anterior segment parameters, amount of synechial closure, and surgical complications. One investigator, who was masked to the surgery performed, examined all patients postoperatively on the first day, and at week 1; months 1, 3, and 6; and 1 year. IOP, number of IOP-lowering drugs needed, best-corrected VA, and complications were recorded. IOP at 1 year was considered as the final IOP for analysis.
Statistical Analysis
Statistical analysis was performed using SPSS software, version 17 (SPSS Inc., Chicago, IL). Student t and w 2 tests were used for comparing parametric quantitative and qualitative variables between groups, respectively. The paired t test was used to compare differences between preoperative and postoperative parametric data in the same group. For nonparametric variables, Mann-Whitney U test used. The Pearson correlation was used to assess the associations between preoperative variables and the changes in IOP. Linear regressions were performed with change in IOP as the dependent variables and the relevant predictive factors as covariates. Finally age, sex, and factors significant at a level of P < 0.20 in linear regression were included in the multivariate regression analysis. P-value of <0.05 was considered statistically significant. The data from the patients who had major intraoperative or postoperative complications (eg, vitreous loss or endophthalmitis) were not included for the analysis.
RESULTS
Of 101 eyes, 91 eyes of 82 patients with PACG and coexisting cataract completed this randomized clinical trial study (Fig. 1 ). Of these 91 eyes, 46 were randomized into the "Phaco alone" treatment group and 45 were randomized into the "Phaco-VGP" treatment group. The demographic characteristics and baseline clinical status are shown in Table 1 . There was no statistically significant difference between the groups according to these baseline characteristics. VA increased significantly in the "Phaco alone" and "Phaco-VGP" groups. Figure 2 compares the IOP profiles of the 2 groups of patients. Phaco alone reduced the mean IOP from a preoperative level of 22.3 ± 6.3 mm Hg (range, 10.0 to 34.0 mm Hg) to 14.0 ± 3.7 mm Hg (range, 9.0 to 24.0 mm Hg) at 12 months after surgery, that is, a 37% reduction (P = 0.001, paired t test). Phaco with adjunctive VGP reduced the mean IOP from a preoperative level of 23.3 ± 7.3 mm Hg (range, 10.0 to 34.0 mm Hg) to 14.5 ± 2.5 mm Hg (range, 10 to 21 mm Hg) at 12 months after surgery, that is, a 38% reduction (P = 0.001, paired t test).
In both the groups the mean postoperative IOPs at all postoperative time points up to 12 months were statistically significantly lower (P < 0.001, paired t test) than the mean preoperative IOP. However, there were no statistically significant differences between the 2 groups in IOP at all follow-up times (Table 2 ). This is also true for change in IOP at final follow-up compared to preoperative values (À 8.3 ± 6.8 vs. À8.8 ± 8.4 mm Hg for Phaco and Phaco-VGP groups, respectively).
Both groups had significantly reduced mean number of glaucoma medications at all postoperative times compared with their preoperative status (P < 0.001) ( Table 2) . However, there were no statistically significant differences between the 2 groups in terms of number of medications at all follow-up times. Table 3 summarizes the preoperative and postoperative gonioscopic and AS-OCT findings in the 2 treatment groups. There was no statistically significant difference between the 2 groups in the extent of synechial angle closure before surgery or 1 year after surgery (P = 0.30 and P = 0.28, respectively). However, within both the treatment groups, there was a statistically significant reduction in the mean extent of synechial angle closure at final follow-up, compared with the preoperative extent (P < 0.001 for both groups). Moreover, the amount of change in PAS in the "Phaco-VGP" group was significantly greater than in the control group (P = 0.004). Gonioscopic measurements indicated an improvement in angle width in both the groups (P < 0.001 for both). TISA500 and TISA750 measured by AS-OCT increased significantly in both groups after surgery. However, the amount of the increase was significantly higher in the "Phaco-VGP" (P = 0.04 and P = 0.03, for TISA500 and TISA750, respectively).
In whole group, the amount of decrease in IOP at 1 year correlated only with preoperative IOP (correlation coefficient = À0.91, P < 0.001) (Fig. 3) . After multivariable regression, preoperative IOP (b = À0.891, P < 0.001) and female sex (b = 2.75, P = 0.02) were the only variables that were associated with changes in IOP after 1 year (Table 4) .
None of the cases developed vitreous loss or endophthalmitis. Four patients in the "Phaco-VGP" and 2 in the "Phaco alone" group developed fibrin reaction postoperatively that resolved after a few days. There were no prolonged uveitic episodes or significant iris trauma documented postoperatively. In addition, 3 patients in the "Phaco-VGP" group developed hyphema intraoperatively that subsided within seconds by viscotamponade.
DISCUSSION
In this randomized controlled study of the effect of adjunctive VGP on IOP, we found a 37% and 38% decrease in IOP in the Phaco alone and Phaco-VGP groups, respectively. Although the change in IOP was not significantly different between groups, the Phaco-VGP group showed significantly greater changes in angle parameters and amount of synechial closure reduction.
The occurrence of PACG is often associated with the specific anatomic structures of the anterior segment of the eye, including a shallow AC, a narrow angle, and a thick and anteriorly positioned lens. 2, 4, 7, 20, 21 In the past, the preferred practice was to perform cataract extraction combined with trabeculectomy in PACG patients who have a visually significant cataract in association with uncontrolled IOP. 22, 23 However, this combined procedure carries a significant risk of developing postoperative complications like flat AC, bleb leak, malignant glaucoma, and choroidal effusion. 24, 25 On the basis of 2 recent related randomized clinical trials, it appears that phacoemulsification alone is a reasonable surgical alternative to combined phacotrabeculectomy in PACG eyes, whether the preoperative IOP is medically controlled or not. 25, 26 Consistent with our study, Tham and colleagues showed a 33% decrease in IOP after phacoemulsification alone in their PACG patients. Although most of their cases had extensive PAS, they showed a statistically significant reduction in the mean extent of synechial angle closure at 1 year after surgery compared with the preoperative status from 270.0 to 200 degrees. [25] [26] [27] The exact mechanism underlying this IOP reduction is not well understood. Phacoemulsification eliminates the pupillary block component and lessens angle crowding caused by a thick and anteriorly placed lens. 22 The deepening of the AC, the widening of the drainage angle, and the improved access of aqueous to the trabecular meshwork may all contribute to this IOP reduction. 3, [28] [29] [30] [31] However, in patients with PACG and PAS, the trabecular meshwork may remain occluded by PAS despite the AC deepening after Phaco alone. Potentially, the trabecular meshwork can be exposed by breaking PAS with goniosynechialysis. 8, 23 Breaking PAS with goniosynechialysis and possible restoration of trabecular function before further irreversible structural changes progress seems to be a logical approach to the treatment of PACG. 1, 15 Some investigators have evaluated the efficacy of VGP combined with cataract extraction in eyes with acute angle closure glaucoma (AACG). [10] [11] [12] They reported a significant reduction in IOP from 52.1 to 14.1 mm Hg with no residual synechiae across 360 degrees of the angle. A few studies reported the effectiveness of this procedure in management of patients with PACG, as well. Razeghinejad and colleagues showed a significant reduction of IOP from 16.7 to 14.4 mm Hg and from 27.95 to 15.5 mm Hg in medically controlled and uncontrolled patients, respectively. A significant number of their patients did not have PAS and they did not report the change in PAS or amount of open angle postoperatively. 32 In other studies on narrow-angle glaucoma patients, Phaco combined with goniosynechialysis appeared to not only lower IOP in the immediate postoperative period but also maintain a sustained effect over a significant period of time. 16 The same result was shown by Varma et al 9 who used viscoelastic for synechialysis during Phaco.
We demonstrated a similar change in IOP between the "Phaco alone" and "Phaco-VGP" and this might suggest that IOP is not significantly improved by adding VGP when doing Phaco. Varma and colleagues showed in a randomized controlled trial of 50 eyes that there was a greater reduction in IOP in patients who had undergone Phaco and VGP than patients who had Phaco alone. However, the amount of PAS before and after surgery and the results of gonioscopic were not available. Including patients with AACG and excluding those with plateau iris syndrome might also be other reasons for their findings. 13 In fact, the procedure has been shown to be more effective in eyes with a previously documented acute symptomatic presentation of angle closure. 16 The results brought out the concept of trabecular function. When the trabecular meshwork function is subnormal, even if the drainage angle is open, the aqueous drainage outflow is still reduced. Theoretically, the longer duration the angle is closed, the higher the chance of trabecular dysfunction.
Although some investigators reported a reduction of PAS extent after performing Phaco and goniosynechialysis in patients with AACG 8 or PACG, 17,32 mechanical deepening of the AC with viscoelastic and saline infusion during Phaco alone may also open some PAS. 33 In the present study, PAS extent decreased significantly after both procedures. However, the change in PAS extent in the "Phaco-VGP" group was significantly higher than in the "Phaco alone" group. Injection of high-molecular weight viscoelastics near the angle seems to have additional effect in the reduction of PAS extent. It was not surprising to see that in both the procedures TISA500 and TISA750 increased and a significantly greater increase was observed in "Phaco-VGP" group.
Interestingly, we found the preoperative angle findings was not a determinant of postoperative IOP in 1 year. Other studies also show little correlation between the degree of preoperative PAS and IOP control after cataract extraction in PACG. 34, 35 Possible explanations include: (1) surgical manipulation, such as viscoelastic agent injection and positive flushing pressure may resolve those PAS that is of weak adherence 36 ; and (2) there is a similar amount of increase in angle parameters between those with PAS and without PAS. 30 Moreover, gonioscopic appearance may not truly reflect the extent of damage in the trabecular meshwork, the loss of trabecular cells, and the irregular architecture of the trabeculum that might exist in areas away from visible PAS or under the PAS. 37 The result of univariate analysis and multiple regressions showed a significant negative association between 32 did not find any serious complications in their series of patients who underwent VGP, we encountered more fibrin reaction in the "Phaco-VGP" group compared to the "Phaco alone" group. However, VGP seems to be a much safer procedure than synechialysis done by knife or blunt spatula.
The results of our study should be interpreted with its limitations in mind. One limitation of the AS-OCT used in this study is that it obtains a cross-section of the anterior segment along 1 meridian and is unable to adequately assess the extent of PAS. Although a glaucoma specialist measured PAS extent in degrees based on indentation gonioscopy, subjective evaluation of PAS might be an estimate and has some variability. Anterior segment sweptsource OCT, which was developed recently, has greater resolution and a much faster imaging speed based on Fourier-domain technology, making it possible to sequentially analyze a greater range of the angle and might be a better instrument for measuring change in iridotrabecular angle during follow-ups. For our study, we chose to perform only the standard horizontal scan as visibility of the vertical angles often requires manipulation of the eyelids which may affect the anterior segment and thus measurements of the angle parameters. Secondly, we evaluated the additional effect of viscosynechialysis to phacoemulsification; however, the results from this study may not be generalizable to the other methods of synechialysis such as manual ones. Finally, although we found only a difference of 0.5 mm Hg in IOP change between groups, our study had low power for detection of difference in the variable "change in IOP" (0.07). This might be due to high SD of IOP change in our cases in both the groups.
In conclusion, our randomized clinical trial showed that both Phaco-VGP and Phaco alone resulted in reduction of IOP and glaucoma medications after 1 year, opening of the drainage angle, deepening of the AC, and reduction of PAS extent in PACG eyes. Although the changes in angle parameters were significantly higher when VGP was employed as an adjunct with phacoemulsification, IOP changes after 1 year were similar in both groups. 
